Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sumatriptan Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,162Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Gets FDA Final Nod For Sumatriptan Injection USP
    Alembic Gets FDA Final Nod For Sumatriptan Injection USP

    09 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/alembic-receives-fda-final-approval-for-sumatriptan-injection-usp-18181

    INDPHARMAPOST
    09 Nov 2025
    Share Share
    Listing of New Products New Generics In NHI Drug Price Standard
    Listing of New Products New Generics In NHI Drug Price Standard

    05 Nov 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release241205.pdf

    PRESS RELEASE
    05 Nov 2024
    Share Share
    Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch
    Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch

    27 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/27/2954413/28908/en/Tonix-Pharmaceuticals-Announces-Issuance-of-U-S-Patent-Covering-the-Subcutaneous-Delivery-of-FDA-Approved-Zembrace-SymTouch-to-Treat-Migraines.html

    GLOBENEWSWIRE
    27 Sep 2024
    Share Share
    Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds
    Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds

    06 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942065/28908/en/Tonix-Pharmaceuticals-Launches-National-Awareness-Campaign-on-the-Impact-of-Gastroparesis-or-Stomach-Paralysis-on-the-Absorption-of-Oral-Migraine-Medications-at-PAINWeek.html

    GLOBENEWSWIRE
    06 Sep 2024
    Share Share
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    Tonix Presents Migraine Treatment Data At AHS Meeting
    Tonix Presents Migraine Treatment Data At AHS Meeting

    18 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900367/28908/en/Tonix-Pharmaceuticals-Presented-Data-Comparing-Real-World-Treatment-of-Migraine-with-Industry-Guidelines-for-Non-Oral-Products-at-the-Annual-Scientific-Meeting-of-the-American-Head.html

    GLOBENEWSWIRE
    18 Jun 2024
    Share Share